PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
4.69%
Growth of 4.69% versus flat Healthcare revenue. Walter Schloss would verify growth quality.
5.49%
Cost growth of 5.49% versus flat Healthcare costs. Walter Schloss would verify cost control.
1.43%
Growth of 1.43% versus flat Healthcare gross profit. Walter Schloss would verify quality.
-3.11%
Margin decline while Healthcare median is 0.00%. Seth Klarman would investigate competitive position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-3.72%
Other expenses reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
1.10%
Operating expenses growth exceeding 1.5x Healthcare median of 0.31%. Jim Chanos would check for waste.
4.77%
Total costs growth exceeding 1.5x Healthcare median of 0.69%. Jim Chanos would check for waste.
17.39%
Interest expense change of 17.39% versus flat Healthcare costs. Walter Schloss would verify control.
-3.38%
D&A reduction while Healthcare median is 0.99%. Seth Klarman would investigate efficiency.
10.35%
EBITDA growth exceeding 1.5x Healthcare median of 1.78%. Joel Greenblatt would investigate advantages.
5.41%
Margin change of 5.41% versus flat Healthcare. Walter Schloss would verify quality.
2.77%
Operating income growth exceeding 1.5x Healthcare median of 0.86%. Joel Greenblatt would investigate advantages.
-1.84%
Operating margin decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
76.47%
Other expenses change of 76.47% versus flat Healthcare. Walter Schloss would verify control.
10.32%
Pre-tax income growth exceeding 1.5x Healthcare median of 1.57%. Joel Greenblatt would investigate advantages.
5.38%
Margin change of 5.38% versus flat Healthcare. Walter Schloss would verify quality.
9.71%
Tax expense change of 9.71% versus flat Healthcare. Walter Schloss would verify strategy.
10.77%
Net income growth exceeding 1.5x Healthcare median of 3.39%. Joel Greenblatt would investigate advantages.
5.81%
Margin change of 5.81% versus flat Healthcare. Walter Schloss would verify quality.
10.76%
EPS growth exceeding 1.5x Healthcare median of 6.43%. Joel Greenblatt would investigate advantages.
10.76%
Diluted EPS growth exceeding 1.5x Healthcare median of 6.22%. Joel Greenblatt would investigate advantages.
-0.00%
Share count reduction while Healthcare median is 0.12%. Seth Klarman would investigate strategy.
-0.00%
Diluted share reduction while Healthcare median is 0.12%. Seth Klarman would investigate strategy.